Competence against insufficiency: Why are men mostly safe from a rare and deadly prostate cancer?

Mathew, G., Trotman, L. C. (June 2020) Competence against insufficiency: Why are men mostly safe from a rare and deadly prostate cancer? Journal of Experimental Medicine, 217 (6). e20200087. ISSN 0022-1007

URL: https://pubmed.ncbi.nlm.nih.gov/32236496/
DOI: 10.1084/jem.20200087

Abstract

Prostate cancer is a slow-growing disease, but not always. A highly rare and lethal form of the disease shows survival rates of less than a year. It is called squamous cell prostate carcinoma. In this issue of JEM, Hermanova et al. (https://doi.org/10.1084/jem.20191787) provide new findings in mouse demonstrating a strong genetic handle on both the reasons behind the rarity and the aggressiveness.

Item Type: Paper
Subjects: diseases & disorders > cancer > cancer types > prostate cancer
CSHL Authors:
Communities: CSHL labs > Trotman lab
Depositing User: Matthew Dunn
Date: June 2020
Date Deposited: 06 Jul 2020 16:43
Last Modified: 29 Jun 2021 16:04
PMCID: PMC7971130
Related URLs:
URI: https://repository.cshl.edu/id/eprint/39502

Actions (login required)

Administrator's edit/view item Administrator's edit/view item
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving